Lung Cancer News and reporting on lung cancer. Feb 23, 2023 Roche to Terminate Gavreto Deal With Blueprint Medicines Feb 13, 2023 Hillstream BioPharma Inks Option Deal With ABSI to Develop HER2-, HER3-Targeted Cancer Drugs Feb 9, 2023 AstraZeneca's Oncology Drug Sales Grew 12 Percent in Q4 2022, Buoyed by Tagrisso, Enhertu Premium Feb 3, 2023 Gilead Sciences Reports Q4 Sales Growth for Trodelvy, CAR T-Cell Therapies Premium Feb 2, 2023 Merck's Keytruda Sales Increase 19 Percent in Q4; Lynparza Reaches Blockbuster Status in 2022 Premium Jan 31, 2023 Pfizer Q4 Oncology Revenues Fall 7 Percent Premium Jan 23, 2023 Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment Jan 20, 2023 Mirati Therapeutics' KRAS G12D Inhibitor Cleared by FDA to Begin Phase I/II Trial Jan 18, 2023 Penn Scientists Testing Out CAR T-Cell Therapy Gel to Prevent Breast Cancer Recurrence Post-Surgery Premium Jan 11, 2023 Bio4t2 Begins Dosing Solid Tumor Patients in First-In-Human CAR T-Cell Therapy Trial Jan 5, 2023 Tempus, AstraZeneca Collaborate on Response Biomarker Discovery for Small Cell Lung Cancer Jan 4, 2023 FDA Approves Foundation Medicine Blood Test as CDx for Rozlytrek Dec 22, 2022 Gilead Sciences, Arcus Biosciences Tout Domvanalimab NSCLC Data as Good News for Anti-TIGIT Approach Premium Dec 21, 2022 Japanese Lung Cancer Genomic Screening Project Expands in Asia-Pacific Dec 21, 2022 FDA Approves Foundation Medicine Assay as CDx for Certain NSCLC Therapies Dec 14, 2022 NewStem, MSK Innovation Hub Team to Validate Cancer Diagnostics Software Platform Dec 12, 2022 T-Cell Subpopulations in Blood May Help Predict Immune Checkpoint Immunotherapy Side Effects Nov 28, 2022 Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment Nov 22, 2022 Legend Biotech to Launch CAR T-Cell Therapy Trial for Small Cell Lung Cancer, Neuroendocrine Tumors Nov 15, 2022 Owkin, Stanford Medicine Collaborate on AI-Driven Lung Cancer, Mesothelioma Biomarker Discovery Load More Breaking News Apollomics Completes SPAC Merger, Begins Public Trading on Nasdaq Ablaze Pharmaceuticals to Develop RayzeBio's GPC3-Targeted Radiotherapy In Brief This Week: Allarity Therapeutics, Immutep, Thermo Fisher Scientific EMA's CHMP Recommends BMS's Breyanzi as Second-Line Lymphoma Treatment Exai Bio, Quantum Leap Healthcare Collaborative Expand Participation in RNA Liquid Biopsy Trial Omega Therapeutics, Roche Partner for Phase I/II Trial in MYC-Driven Hepatocellular Carcinoma